NCT05400824 Metabolic and Infectious Diseases in La Réunion (the REUNION Population-based Study)
| NCT ID | NCT05400824 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Institut National de la Santé Et de la Recherche Médicale, France |
| Condition | Infectious Disease |
| Study Type | OBSERVATIONAL |
| Enrollment | 2,000 participants |
| Start Date | 2022-05-01 |
| Primary Completion | 2027-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 2,000 participants in total. It began in 2022-05-01 with a primary completion date of 2027-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The aim of the present study is to determine the prevalence of cardiometabolic and infectious disease in La Reunion (french oversea department and region of France). Known or suspected risk factor for these diseases will also be assessed, such as microbiota, cognitive impairement, social inequalities, and genetics.
Eligibility Criteria
Inclusion Criteria: * 18-67 years * given consent for genetic analysis, * written consent for participating in the study Exclusion Criteria: * judicial protection or guardianship
Contact & Investigator
Maxime COURNOT, MD, PhD
PRINCIPAL INVESTIGATOR
Institut National de la Santé Et de la Recherche Médicale, France
Frequently Asked Questions
Who can join the NCT05400824 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 67 Years, studying Infectious Disease. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05400824 currently recruiting?
Yes, NCT05400824 is actively recruiting participants. Contact the research team at maxime.cournot@inserm.fr for enrollment information.
Where is the NCT05400824 trial being conducted?
This trial is being conducted at La Réunion, France.
Who is sponsoring the NCT05400824 clinical trial?
NCT05400824 is sponsored by Institut National de la Santé Et de la Recherche Médicale, France. The principal investigator is Maxime COURNOT, MD, PhD at Institut National de la Santé Et de la Recherche Médicale, France. The trial plans to enroll 2,000 participants.